<SEC-DOCUMENT>0001193125-16-779393.txt : 20161129
<SEC-HEADER>0001193125-16-779393.hdr.sgml : 20161129
<ACCEPTANCE-DATETIME>20161129141702
ACCESSION NUMBER:		0001193125-16-779393
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20161129
FILED AS OF DATE:		20161129
DATE AS OF CHANGE:		20161129

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EMERA INC
		CENTRAL INDEX KEY:			0001127248
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRIC SERVICES [4911]
		IRS NUMBER:				868143132
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54516
		FILM NUMBER:		162022307

	BUSINESS ADDRESS:	
		STREET 1:		1223 LOWER WATER ST., B-6TH FLOOR
		STREET 2:		P.O. BOX 910
		CITY:			HALIFAX
		STATE:			A5
		ZIP:			B3J 3S8
		BUSINESS PHONE:		902-428-6494

	MAIL ADDRESS:	
		STREET 1:		1223 LOWER WATER ST., B-6TH FLOOR
		STREET 2:		P.O. BOX 910
		CITY:			HALIFAX
		STATE:			A5
		ZIP:			B3J 3S8
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d301054d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF
FOREIGN PRIVATE ISSUER </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE <FONT STYLE="white-space:nowrap">13a-16</FONT> OR
<FONT STYLE="white-space:nowrap">15d-16</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of November, 2016 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number: 000-54516 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Emera
Incorporated </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>5151 Terminal Road </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Halifax NS B3J 1A1 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Canada </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of
principal executive offices) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under cover of Form
<FONT STYLE="white-space:nowrap">20-F</FONT> or <FONT STYLE="white-space:nowrap">Form&nbsp;40-F.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">Form&nbsp;20-F&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> Form <FONT STYLE="white-space:nowrap">40-F&nbsp;&nbsp;&#9745;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check
mark if the registrant is submitting the Form <FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(1):&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by
Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(7):&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"><B>EMERA INCORPORATED</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Date: November 29, 2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Wayne D. O&#146;Connor</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Wayne D. O&#146;Connor</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Vice-President Corporate</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Strategy
and Planning</P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.10pt; font-size:8pt; font-family:Times New Roman"><B>Exhibit&nbsp;No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press release dated as of November&nbsp;28, 2016</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d301054dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g301054image000180.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Emera Announces Bought Deal Offering of 6,630,000 Common Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OR FOR DISSEMINATION IN THE UNITED STATES. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>HALIFAX, Nova Scotia, November&nbsp;28, 2016</B>: Emera Incorporated (&#147;Emera&#148;) (TSX:EMA) announced today that it has entered into an agreement
with a syndicate led by TD Securities Inc., CIBC Capital Markets, RBC Capital Markets and Scotiabank, under which they have agreed to purchase from Emera and sell to the public 6,630,000 Common Shares of Emera. The underwriters will also have the
option to purchase up to an additional 994,500 Common Shares to cover overallotments, if any, and for market stabilization purposes, during the 30 days following the closing of the offering (the &#147;Over-Allotment Option&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purchase price of $45.25 per Common Share will result in gross proceeds to Emera of $300,007,500 ($345,008,625 if the Over-Allotment Option is exercised
in full). The net proceeds of the offering will be used for general corporate purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The offering is subject to the receipt of all necessary
regulatory and stock exchange approvals. Closing is expected to occur on or about December&nbsp;16, 2016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Common Shares have not been registered
under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This media release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any offer, solicitation or sale of the securities in any province, state or jurisdiction in which such offer, solicitation or sale would be unlawful. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release contains
forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information requires Emera to make assumptions and is subject to inherent risks and uncertainties. These statements reflect Emera
management&#146;s current beliefs and are based on information currently available to Emera management. There is a risk that predictions, forecasts, conclusions and projections that constitute forward-looking information will not prove to be
accurate, that Emera&#146;s assumptions may not be correct and that actual results may differ materially from such forward-looking information. Additional detailed information about these assumptions, risks and uncertainties is included in
Emera&#146;s securities regulatory filings, including under the heading &#147;Business Risks and Risk Management&#148; in Emera&#146;s annual Management&#146;s Discussion and Analysis, and under the heading &#147;Principal Risks and
Uncertainties&#148; in the notes to Emera&#146;s annual and interim financial statements, which can be found on SEDAR at <U>www.sedar.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About
Emera Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emera Inc. is a geographically diverse energy and services company headquartered in Halifax, Nova Scotia with approximately $28 billion in
assets and 2015 pro-forma revenues of $6.3 billion. The company invests in electricity generation, transmission and distribution, gas transmission and distribution, and utility energy services with a strategic focus on transformation from high
carbon to low carbon energy sources. Emera has investments throughout North America, and in four Caribbean countries. Emera continues to target having 75-85% of its adjusted earnings come from rate-regulated businesses. Emera&#146;s common and
preferred shares are listed on the Toronto Stock Exchange and trade respectively under the symbol EMA, EMA.PR.A, EMA.PR.B, EMA.PR.C, EMA.PR.E, and EMA.PR.F. Depositary receipts representing common shares of Emera are listed on the Barbados Stock
Exchange under the symbol EMABDR. Additional Information can be accessed at <U>www.emera.com</U> or at <U>www.sedar.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For more information,
please contact: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mark Kane </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Investor
Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(813) 228-1772 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>mark.kane@emera.com </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neera Ritcey </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Manager, Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(902) 428-6059 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>neera.ritcey@emera.com </U></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g301054image000180.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g301054image000180.jpg
M_]C_X  02D9)1@ ! 0$ W #=  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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M+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH 2F311SQF.9%D1A@JPR#^%%% CE=0^&OA6^<R-IBP,3D^
M0QC'Y#C]*99_#+PI:N'&F^<1R/.D9A^72BBM57JVMS,S]A3O?E1U%G9VMC&L
M-G;16\8Z+$@4#\!5FBBL;MZLT2ML%%%%,84444 %%%% !1110 4444 %%%%
;!1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
